Cyberonics expands US sales force:
This article was originally published in Clinica
Executive Summary
Cyberonics is to expand its US sales force to follow up the launch last year of its NeuroCybernetic Prosthesis, a vagus nerve stimulator, for the treatment of epilepsy. The Houston-based company plans to complete hiring new staff by mid-June. It said that 839 systems have been ordered since its launch nine months ago. Cyberonics' president and CEO, Robert Cummins, said that the company had realised that it had reached its maximum sales and marketing capacity in the third quarter of fiscal 1998, and expected little or no quarter-to-quarter revenue growth in the fourth quarter.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.